HC Wainwright & Co. Maintains Buy on Instil Bio, Raises Price Target to $40
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has maintained a Buy rating on Instil Bio and raised the price target from $25 to $40, indicating a positive outlook for the company's stock.
September 12, 2024 | 10:23 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has maintained a Buy rating on Instil Bio and increased the price target from $25 to $40, suggesting confidence in the company's future performance.
The increase in price target from $25 to $40 by HC Wainwright & Co. reflects a strong positive sentiment and confidence in Instil Bio's future performance. This is likely to attract investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100